The board of director(s) of Baytacare Pharmaceutical Co., Ltd. announced that the Company has on 8 June 2018, entered into (1) a strategic framework agreement (the "Framework Agreement"); and (2) an agency agreement, with Zhuhai Guangyuan Co., Ltd., to enhance the sales and distribution channel of the Company's products, and to allow the Company to act as the authorised dealer of Zhuhai Guangyuan in Jilin Province, China. Under the Framework Agreement, the Company and Zhuhai Guangyuan aim to achieve the following: Promote cooperation between Zhuhai Guangyuan and the Group in the area of pharmacy chain; Promote comprehensive cooperation through integration of membership management of Zhuhai Guangyuan's pharmacy chain stores and the Company's Beidou big data healthcare management capabilities; Facilitate in-depth cooperation between the Group and Zhuhai Guangyuan in the area of pharmaceutical distribution; Reduce production and processing costs of the existing processed Chinese herbal medicine of Zhuhai Guangyuan and promote the circulation of the Group's Chinese herbal medicine planting products.